A critical breakthrough in cancer investigation is arising with the use of VHH fragments to re-engage damaged p53. This essential cancer suppressor protein is frequently inactivated in various forms of malignancies, https://top100bookmark.com/story22126279/mini-antibodies-reactivate-the-p53-protein-new-potential-approach-for-tumor-therapy